← Back to Patent Explorer
US4356184A Expired / Lapsed US ⏱️ 0.0 years remaining

Anti-allergic or antihypertensive 1-piperidinylmethyl benzenamines

Assignee: GD Searle LLC
•
Filing: 1981-03-25
•
Granted: 1982-10-26
•
Expires: 2001-03-25
📄 Original PDF 🌐 Google Patents 🔄 Sync Now

Abstract

Abstract 1-Piperidinylmethyl benzenamines represented by the formula: ##STR1## wherein X is S or --CH 2 --CH 2 --; R 1 and R 2 are the same different members of the group consisting of hydrogen or lower alkyl; and the pharmaceutically acceptable salts thereof. The compounds are useful as anti-allergic and antihypertensive agents.

Inventors

  • 👤 James R. Deason
  • 👤 Richard A. Partis

Bibliographic Details

Application Number —
Jurisdiction US
Data Source google_patents
Last Synchronized 2026-11-03 22:16
CPC Classifications
C; C07; C07D; C07D409/00; C07D409/02; C07D409/04; C07D211/00; C07D211/04; C07D211/68; C07D211/70

Claims Analysis

Total Claims: 9
Claim 1
Independent Claim 45 words
A 1-piperidinylmethyl benzenamine represented by the formula: ##STR6## wherein: X is --S-- or --CH 2 --CH 2 --; and R 1 and R 2 are the same or different members of the group consisting of hydrogen or loweralkyl; or a the pharmaceutically acceptable salt thereof.
Claim 2
Dependent Claim 45 words
A 1-piperidinylmethyl benzenamine represented by the formula: ##STR6## wherein: X is --S-- or --CH 2 --CH 2 --; and R 1 and R 2 are the same or different members of the group consisting of hydrogen or loweralkyl; or a the pharmaceutically acceptable salt thereof.
Claim 3
Dependent Claim 30 words
A compound of claim 1 wherein X is --S-- and the compound is represented by the Formula: ##STR7## wherein R 1 and R 2 are as defined in claim 1.
Claim 4
Dependent Claim 12 words
A compound of claim 2; N,N-dimethyl-4-[4-(9H-thioxanthene-9-ylidene)-1-piperidinylmethyl]-benzenamine or a pharmaceutically acceptable salt thereof.
Claim 5
Dependent Claim 34 words
A compound of claim 1 wherein X is --CH 2 --CH 2 -- and the compound is represented by the formula ##STR8## wherein R 1 and R 2 are as defined in claim 1.
Claim 6
Dependent Claim 12 words
A compound of claim 4: N,N-dimethyl-4-[4-(5H-dibenzo[a,d]cycloheptan-5-ylidene)-1-piperidinylmethyl]benzenamine or a pharmaceutically acceptable salt thereof.
Claim 7
Dependent Claim 24 words
An anti-allergic or antihypertensive pharmaceutical composition comprising a therapeutically effective amount of a compound of claim 1 and a pharmaceutically acceptable carrier or diluent.
Claim 8
Dependent Claim 17 words
A pharmaceutical composition of claim 6 wherein said compound is N,N-dimethyl-4-[4-(9H-thioxanthene-9-ylidine)-1-piperidinylmethyl]-benzenamine or a pharmaceutically acceptable salt thereof.
Claim 9
Dependent Claim 17 words
A pharmaceutical composition of claim 6 wherein said compound is N,N-dimethyl-4-[4-(5H-dibenzo[a,d]cycloheptan-5-ylidene-1-piperidinylmethyl]benzenamine or a pharmaceutically acceptable salt thereof.

References Cited (Backward Citations)

CA746508A Cited
US3014911A Cited
GB1103718A Cited
FR1516783A Cited
DE2256392A1 Cited
US3862156A Cited
US4275209A Cited

USPTO Annuity & Maintenance Windows

Annuity Stage Window Opens Payment Deadline Surcharge Period Until Estimated Fee Status
3.5 Years (Year 4) 1985-10-25 1986-04-26 1986-10-26 $2000.00 Window Closed / Lapsed
7.5 Years (Year 8) 1989-10-25 1990-04-26 1990-10-26 $3760.00 Window Closed / Lapsed
11.5 Years (Year 12) 1993-10-25 1994-04-26 1994-10-26 $7700.00 Window Closed / Lapsed

Assigned Categories & Tags

No categories assigned to this patent yet.

Assign Category Tag